Teamwork: FDA And NIH Join Forces To Fund Neurodegenerative Disease Research, Medical Device Development Tools

The two federal agencies are working together to research rare conditions and fund grants for small businesses creating medical device development tools.

Business team connecting pieces of gears.
• Source: Shutterstock

The US Food and Drug Administration and National Institutes of Health are working together on two separate projects that aim to advance novel treatments, the FDA has recently announced.

The first project, the Critical Path for Rare Neurodegenerative Diseases (CP-RND), is a public-private partnership to develop better understanding...

More from Regulation

More from Policy & Regulation